Healthcare infrastructure development and increased funding are likely to drive demand for pharmerging.Wilmington, Delaware, ...

GEORGIA AVENUE, WA, UNITED STATES, October 17, 2024 /EINPresswire / -- The latest release from Vantage <a target=_blank href= ...

If a company's history and track record were good enough reasons to buy its shares, it'd be easy to make a case for investing ...

Electronic nudges had a small impact on flu vaccine uptake in patients without diabetes but showed no significant effect ...

Continuous monitors track blood glucose levels 24 hours a day through a sensor just under your skin, replacing finger-prick testing. They are widely funded and used overseas. The monitors alert users ...

Event featuring David T. Ahn, MD from Hoag Medical Group and Jeff Ciaramita, MD from Mercy health system, along with ...

Robert Ford’s comments come as new CGMs and insulin pumps continue to roll out in the diabetes tech space, including over-the-counter glucose sensors.

Abbott's recent results show 7.6% organic revenue growth, driven by medical devices and pharmaceuticals. Click here to read ...

Automated insulin delivery systems not only improved glycemic endpoints but also alleviated disease burden and enhanced ...

Abbott has raised the midpoint of its full-year income guidance as the group was bolstered by solid sales of medical devices ...

Abbott Laboratories narrowed its full-year profit outlook, raising the midpoint slightly, as strong demand for its diabetes ...

Not everyone in the health field is so bullish on the prospects of CGMs for everyone, and question whether digging in too ...